Prevalence and risk factor for intrauterine growth restriction among pregnancy-induced hypertension patient


  • Varuni Sharma Department of Obstetrics and Gynecology, M. M. Institute of Medical Sciences and Research, M.M Deemed to be University Mullana, Ambala, Haryana, India
  • Navin Shukla Department of ENT, M. M. Institute of Medical Sciences and Research, M.M Deemed to be University Mullana, Ambala, Haryana, India



Intrauterine growth restriction, Pregnancy-induced hypertension, Prevalence


Background: Hypertensive disorders in pregnancy (HDP) remain a major global health issue not only because of the associated high adverse maternal outcomes but there is a close accompaniment of significant perinatal morbidity. Intrauterine growth restriction (IUGR), a condition that occurs due to various reasons, is an important cause of fetal. It has been defined as a rate of fetal growth that is less than normal in light of the growth potential of that specific infant. The aim of this study is to evaluate the prevalence and risk factor for IUGR among the PIH patient.

Methods: A prospective randomized controlled clinical trial of 25 patients was carried out in Kamla Raja Hospital and Out Patient Department of Gajra Raja Medical College, Gwalior from October 6th to October 2007. A total number of 25 patients were included in study of PIH.

Results: conclude that the prevalence and risk factor for IUGR among the PIH patient.  The Distribution prevalence of sociodemographical factor for IUGR among PIH patient is statistically not significant. It concluded that there is no significance (no effect) between risk factors of IUGR among the pregnancy induced hypertension.

Conclusions: The prevalence of IUGR found in this study. There is need to increase awareness among medical and paramedical personnel on the need for early referral of women with previous history of IUGR, preeclampsia, multiple gestations, gestational diabetes and obesity for specialist care as they have a higher risk.


Xiong X, Fraser WD. Impact of pregnancy-induced hypertension on birth weight by gestational age. Paediatr Perin Epidemio. 2004;18:186-91.

Somerset DJ. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. Obstet Gynaecol Can. 2014;36(7):57.

PubMedDuley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-7.

Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967;71(2):159-63.

Mandruzzato G. Intrauterine restriction (IUGR). J Perinat Med. 2008;36:277-81.

Brodsky D, Christou H. Current concept in intrauterine growth resteiction. J int Care Med. 2003;19:307-19.

Aucott SW, Donohue PK, Northington FJ. Increased morbidity in severe early intrauterine growth restriction. J Perinatol. 2004;24:435-40.

Lapillone A, Peretti N, Ho PS, Claris O, Salle BL. Aetiology, morphology and body composition of infants born small for gestational age. Acta Paediatr Suppl. 1997;423:173-6.

Crovetto F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Figueras F, et al. Differential performance of first trimester screening in predicting small for gestational age neonates or fetal growth restriction. Ultrasound Obstet Gynecol. 2016;49:349-56.

Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Repro. 2004;127(5):515-26.

Chesley LC. Hypertensive disorders in pregnancy. New York: Appleton-Century- Crofts; 1978.

Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr. 2004:2169-72.

Goldenberg RL, Cutter GR, Hoffman HJ, Foster JM, Nelson KG, Hauth JC. Intrauterine growth retardation: Standards for diagnosis. Am J Obstet Gynecol. 1989;161:271-7.

World Health Organization. Women's health. Fact sheet N°334. 2013. Available at: Accessed on 11th July 2017.

Sachdeva PD, Patel BG, Bhatt MV. A study of incidence and management of pregnancy induced hypertension in Central Gujarat, India. Int J Univer Pharma Life Sci. 2011;1(3):61-70.

Anna L, Millar S, Lynnae K. To relate hypothyroidism to perinatal outcome. March. 1993;161:271-7.

National study on essential obstetric care facilities in Nigeria. Federal Ministry of Health, Abuja, Nigeria. 2003:37.

Chauhan SP, Taylor M, Shields D, Parker D, Scardo JA, Magann EF. Intrauterine growth restriction and oligohydramnios among high-risk patients. Am J Perinatol. 2007;24(4):215-21.

Lindblad B, Zaman S, Malik A. Vitamin B12, and homocysteine levels in South Asian Women with growth-retarded fetuses. Obstet Gynecol Surv. 2006;61:91-2.

Jansson T, Ylven K, Wennergren M, Powell TL. Glucose transport and system a activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta. 2002;23:392-9.






Original Research Articles